Recordati Industria Chimica e Farmaceutica SpA Overview
Pro stress-test →Recordati is a drug manufacturing company focused on specialty pharmaceuticals that produces and promotes medicines globally for primary-care therapies and rare diseases. The company operates as a global pharmaceutical group with presence in over 150 countries and is marking its centenary in 2026.
Strategic Profile
Pro stress-test →Recordati uses strategic partnerships as part of its long-term growth strategy. The company operates two segments: Specialty and Primary Care, and Rare Diseases, with the bulk of profit derived from specialty and primary care including active ingredient production.
Competitive Landscape
Pro stress-test →Recordati competes with major pharmaceutical companies including Novartis, Cipla, Takeda Pharmaceutical, Shionogi & Co., and Intas Pharmaceuticals among 71 identified competitors. The company's focused strategy on specialty and rare disease markets differentiates it from diversified pharma giants, positioning it as a mid-cap player with distinct therapeutic niche focus.
Industry Context
Recordati Industria Chimica e Farmaceutica SpA operates in Pharmaceuticals.
Key facts
Founded: 1926 · Headquarters: Milan, Italy · Employees: 4,580 · Revenue: $2.82B · Market cap: $11.5B